Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-05-18

FDA Approved: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved a supplemental application for clindamycin phosphate and benzoyl peroxide from Padagis Israel Pharmaceuticals Ltd, a topical acne treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clindamycin Phosphate and Benzoyl Peroxide (clindamycin phosphate and benzoyl peroxide)

Snippet

SUPPL AP for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE (CLINDAMYCIN, BENZOYL PEROXIDE)